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Background: Tang Bi Kang (TBK) is a traditional Chinese medicine granule. It has been shown to have effects
on nerve conduction velocity deficits, blood-related factors and oxidative stress. This study was undertaken to
evaluate proposed antioxidative and anti-inflammatory activity of Tang Bi Kang in rats with diabetic peripheral
neuropathy (DPN).
Methods: DPN was induced in male Wistar rats by intraperitoneal administration of streptozocin (STZ) (60 mg/
kg.b.w) for 8 weeks. Fasting blood glucose (FBG) levels were measured in the blood obtained by clipping the tails
of the rats. Tail-flick tests were conducted with a tail-flick analgesic meter. Motor and sensory nerve conduction
velocities (MNCV and SNCV) of sciatic nerve were measured directly at two sites using a Functional Experiment
System. Oxidative stress makers such as malondialdehyde (MDA), superoxide-dismutase (SOD) and glutathione
peroxidase (GSH-Px), inflammatory cytokines such as interleukin (IL)-6, and tumour necrosis factor (TNF)-α were es-
timated. The statistical analysis of results was carried out using Student t-test and one-way analysis of variance
(ANOVA), followed by least-significant difference post hoc with SPSS.
Results: The administration of TBK for 4 weeks in DPN rats resulted in a significant decrease in FBG levels compared to
untreated DPN rats. There was a significant increase in MNCV and SNCV in the DPN rats compared to untreated DPN
rats. Serum level of MDA was significantly reduced while the activities of SOD and GSH-pX were significantly increased
in the TBK treated DPN rats. TBK prevented DPN-induced increase in the serum levels of IL-6 and TNF-α.
Conclusion: The results of this study demonstrate that the therapeutic effect of TBK on DPN rats may be associated
with the antioxidative and anti-inflammatory responses.
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Diabetic peripheral neuropathy (DPN) is one of the
common complications of diabetes. It is manifested by
MNCV and SNCV deficits as well as by increased
thresholds of thermal perception [1]. The pathogenesis
underlying DPN is multifactorial [2], involving the polyol
pathway, hexosamine pathway, and excess/inappropriate
activation of protein kinase c isoforms, accumulation of* Correspondence: thliu@tom.com; xulp@ccmu.edu.cn
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unless otherwise stated.advanced glycation end products, oxidative stress and
inflammation [3-5].
Hyperglycemia clearly plays a key role in the develop-
ment and progression of diabetic neuropathy, and oxi-
dative stress has been considered the final common
pathway of cellular injury in hyperglycemia [6]. Recent
studies show that oxidative stress and inflammation
interact each other and are inseparably linked to DPN,
particularly in the Nrf2–NF-κB pathway [6-9].
Nuclear factor-erythroid 2-related factor-2 (Nrf2) and
nuclear factor-κB (NF-κB) are two redox regulated tran-
scription factors, involved in oxidative stress, inflamma-
tion, cellular growth and apoptosis [10,11]. Furthermore,his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 1 Recipe of TBK formulation
Latin name Amount (g)
Astragali radix 15.0
Ligustri lucidi fructus 10.0
Cinnamomi ramulus 9.0
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transcription level via protein–protein interactions or
through secondary messenger effects [12,13]. Imbalance
in Nrf2–NF-κB regulation induced by hyperglycaemia is
found to contribute to the pathogenesis of DPN [9].
Enhanced NF-κB activity during the hyperglycemic state
is associated with excess production of proinflammatory
cytokines such as IL-6, TNF-α, cyclooxygenase-2 (COX-2)
and induces the generation of nitric oxide synthase
(iNOS). These proteins and enzymes are mediators pre-
requisite for the initiation and amplification of inflam-
matory processes in neuronal cells [12]. Reduced Nrf2
activity results in impaired antioxidative defense, which
is characterized by decline in SOD, catalase and gluta-
thione levels. Additionally, it decreases the production
of detoxifying enzymes leading to nitrosative and oxida-
tive stress [10].
Neuroinflammation due to elevated NF-κB can activate
neurons and the Schwann cells, which further augments
the release of proinflammatory mediators, resulting in a
vicious cycle of the inflammation. It makes the nerve fi-
bres sensitive to painful and thermal stimulus and results
in sensorimotor alterations [14,15]. The manifestations of
neuroinflammation and oxidative stress can cumulatively
cause the structural damage which can lead to the func-
tional, sensorimotor and biochemical deficits which are
characteristic of diabetic neuropathy [9].
Because DPN does not develop with either temporal
or biochemical uniformity, its therapeutic management
may benefit from a multifaceted approach that inhibits
pathogenic mechanisms [9]. Recent reviews have pointed
out the importance of targeting oxidative stress and in-
flammation in the treatment of DPN [16].
Tang Bi Kang (TBK) is a traditional Chinese medicine
granule compound made from nine herbal medicines in-
cluding Astragali radix, Ligustri lucidi fructus, Cinnamomi
ramulus, Paeoniae radix rubra, Spatholobi caulis, Scutellar-
iae radix, Coptidis rhizoma, Hirudo and Corydalis rhizoma.
Studies have shown that TBK has effects on nerve conduc-
tion velocity deficiency [17] and blood factors such as
endothelin-1, nitric oxide, thromboxane B2, and 6-keto-
prostaglandin [18] in the STZ-induced diabetic rats. In
addition, TBK was found to prevent vascular endothelial
cells from oxidative stress induced by high glucose, which
indirectly plays a role in protection of DPN [19].
Based on the previous studies, we hypothesized that
TBK may be effective to treat DPN by reducing oxidative
stress and inflammation. The aim of this study was to
evaluate the therapeutical effect of TBK on DPN in rats.
Methods
TBK extract
TBK is made up with nine traditional Chinese medicines
(Table 1). All the slices were punched from YanjingShuangqiao Slices Factory (Beijing, China) and were
identified and authenticated by Shiyuan Jin, Honorary
Professor, School of Traditional Chinese Medicine, Capital
Medical University. The voucher specimen of this material
has been deposited in a publicly available herbarium in
School of Traditional Chinese Medicine. Astragali radix,
Ligustri lucidi fructus, Cinnamomi ramulus, Paeoniae
radix rubra and Spatholobi caulis were macerated for 1 h
at room temperature with ten time volumes (v/w) of dis-
tilled water. The mixture was decocted thrice for 2 h each.
The filtrates were mixed and condensed, added with alco-
hol to a concentration of 70%, and concentrated under
reduced pressure at low temperature (40°C to 45°C) in
Buchi rotavapor R-200. Scutellariae radix, Coptidis rhi-
zoma, Hirudo and Corydalis rhizoma were macerated with
six time volumes of (v/w) 70% alcohol, and reflux-
extracted thrice for 1 h each, combined and dried under
reduced pressure. The alcohol extract was 18.5% of total
plant mass. All the extracts were stored at 0°C in airtight
containers for further studies.
Animals
Animal experiments were conducted in accordance with
the NIH Principles of Laboratory Animal Care and the
institutional guidelines for the care and use of laboratory
animals at Capital Medical University (Beijing, China).
Adult male Wistar rats weighing 200 ± 20 g were ob-
tained from the Experimental Animal Center at Capital
Medical University, Beijing, China, with license number
SCXK (Beijing) 2012–0001 and animal experimental eth-
ical inspection number 2013-X-30. The rats were main-
tained on a 12-h/12-h light/dark cycle at 23 ± 2°C and
55 ± 10% relative humidity and allowed free access to
water and standard laboratory chows.
Induction of experimental DPN
In this experiment, a total of 80 rats were used. After over-
night fasting, diabetes was induced by intraperitoneal
Table 2 Experimental groups and treatments
Group N Animals Treatment
Control 10 Normal rats 0.5% sodium carboxymethylcellulose
Mod 10 DPN rats 0.5% sodium carboxymethylcellulose
MCB 10 DPN rats 0.225 mg Mecobalamin/kg b.w.
LTBK 10 DPN rats 4.28 g TBK/kg b.w.
MTBK 10 DPN rats 8.56 g TBK/kg b.w.
HTBK 10 DPN rats 17.12 g TBK/kg b.w.
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(pH 4.5) at a dose of 60 mg/kg using 60 rats. On the third
day, rats with FBG levels greater than 16.7 mmol/L were
treated as diabetic rats and were used for further experi-
ments. For control, 20 rats were treated with the same
volume of cold citrate buffer as the nondiabetic rats.
Eight weeks later, 10 nondiabetic rats and 10 diabetic
rats were randomly chosen to determine the develop-
ment of DPN by measuring FBG, nociceptive threshold,
and then were measured sciatic nerve conduction vel-
ocity and examined for sciatic nerve pathology. All
parameters including slowed conduction velocity, in-
creased tail-flick latency and sciatic nerve segmental de-
myelination and axon atrophy indicated that the model
was successfully established.
Experiment design
A total of 50 DPN rats were randomly divided into four
treatment groups and a DPN model group as described
in Table 2. Rats in three treatment groups were intragas-
trically administered with different concentrations of
TBK (dissolved in 0.5% sodium carboxymethylcellulose)
at 1 ml/100 g once a day for 4 weeks. Another group of
DPN rats were treated with Mecobalamin (MCB). The
DPN model and control groups received 0.5% sodium
carboxymethylcellulose.
Blood glucose
FBG levels were measured biweekly in the blood ob-
tained by clipping the tails of the rats before and after
the diabetic states.
Tail-flick test
Tail-flick latency tests were conducted before and after
the diabetic state at the 4th, 8th, and 12th week. The pain
threshold to a thermal stimulus was assessed by tail-flickTable 3 Parameters of experimental DPN rats
Group N Blood glucose (mmol/L)
Control 10 5.93 ± 0.39
Mod 10 31.64 ± 2.62aa
Data are given as mean ± S.E.M, aaP < 0.01, compared to the Control group.latency evoked by a noxious heat stimulus, as deter-
mined with a tail-flick analgesic meter (YLS-12A, Yi
Yan, Shan Dong, China). In the tail-flick test, radiant
heat was focused on the dorsal tail surface 1 cm from
the tip of the tail. The cut-off time for the tail-flick reac-
tion was set to 16 s to avoid damage to the tail.
Sciatic nerve conduction velocity
After intragastric administration for 4 weeks, the ani-
mals were anesthetized with 10% chloral hydrate (i.p.,
10 ml/kg). The stimulating and recording electrodes
were placed directly under the sciatic nerve of right leg.
The skin was incised and detached between the biceps
femoris and semitendinous muscles to expose the sciatic
nerve at the two sites, to attach electrodes. The stimula-
tion electrode was placed at the sciatic nerve notch, and
distance between the stimulation electrode and record-
ing electrode was 6 mm. The sciatic nerve was stimu-
lated with single square wave pluse (1.2 V in intensity,
1 ms in width) using the Functional Experiment System
(BL-420 s, Taimeng, Sichuan, China). The action poten-
tial latency (L) of sciatic nerve and the distance (D)
between the stimulating and recording electrodes were
measured to calculate the MNCV (MNCV (m/s) = D/L).
For SNCV, the site of recording was located in the
sciatic notch. SNCV was calculated the same as the
MNCV.
Microscopy
After the conduction velocity test, the left sciatic nerve
was isolated and cut into two segments, one segment
(2 mm) was fixed in 2.5% glutaraldehyde kept at 4°C, and
sent to the Electron Microscopy Center of Institute of
Capital Medical University for ultrastructure observation.
The other segment (1 cm) was fixed in 10% buffered for-
malin and processed for paraffin block preparation. Sec-
tions of about 4 μ m transverse and longitudinal thickness
were cut for Hematoxylin-eosin (HE) staining.
Immunochemistry
After the isolation of sciatic nerve, blood samples were
collected, and centrifuged at 3000 rpm for 10 min to
obtain serum. All serum samples were stored at −80°C.
The serum levels of inflammatory markers, including
interleukin (IL)-6 and tumor necrosis factor (TNF)-α
were detected using the commercial enzyme-linkedTail-flick latency MNCV SNCV
(s) (m/s) (m/s)
3.34 ± 0.52 48.96 ± 5.34 41.62 ± 5.22
8.54 ± 1.39aa 25.18 ± 2.94aa 20.39 ± 2.44aa
Figure 1 Histological examination of hematoxylin and eosin (H&E) stained sciatic nerve. (A and C, Control group, showing normal sciatic
nerve; B and D, Mod group, showing sciatic nerve of DNP rats. Magnification, 400× ).
Figure 2 Blood glucose levels in each group. Each bar represents the means ± S.E.M for ten rats. aaP < 0.01 vs. the Control group. bP < 0.05,
bbP < 0.01 vs. the Mod group.
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Figure 3 Thermal perception thresholds in each group. Each bar represents the mean ± S.E.M for ten rats. aP < 0.05 vs. the Control group.
bP < 0.05 vs. the Mod group.
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Shanghai, China). All experimental procedures were per-
formed according to the manufacturer’s instructions.
Oxidative stress
Oxidative stress was evaluated by assessing the contents of
malondialdehyde (MDA), superoxide-dismutase (SOD)
and glutathione peroxidase (GSH-Px). MDA content was
assessed using thiobarbituric acid reactive substances assay
(Jiancheng Bioengineering, Nanjing, China) by measuring
the absorbance value at wavelength of 532 nm. SOD
activity was assessed using the xanthine oxidase method
to measure the absorbance value at 550 nm with a SOD
kit (Jiancheng Bioengineering, Nanjing, China). GSH-PxFigure 4 MNCV and SNCV in Each Group. Each bar represents the mean
bP < 0.05, bbP < 0.01 vs. the Mod group.activity was estimated by the analysis of glutathione in the
enzymatic reaction. Reduction of GSH is catalyzed by
GSH-Px in the presence of hydrogen peroxide. One unit of
enzyme activity represents a decrease in GSH concentra-
tion of 1 μm/ml of serum.
Statistical analysis
The results were presented as means ± S.E.M, statistical
significance was analyzed using Student t-test and one-
way analysis of variance (ANOVA), followed by least-
significant difference post hoc with SPSS for windows
version 17.0. The values were considered to be signifi-
cant when P value was < 0.05.± S.E.M for ten rats. aP < 0.05, aaP < 0.01 vs. the Control group.
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Assessment of the experimental DPN rat model
After 8 weeks of STZ induction, the blood glucose levels
of the rats were significantly higher than those in normal
rats (P < 0.01), indicating the rats were hyperglycemic. A
significant increase in tail flick latency was observed
after 8 weeks of STZ induction (P < 0.01), and MNCV
and SNCV were significantly reduced in the STZ-treated
rats compared to the normal rats (P < 0.01) (Table 3).Figure 5 Sciatic nerves of rats in each group. (A and H, Control group,
sciatic nerve; C and J, MCB group, showing sciatic nerve of DPN rats treate
showing sciatic nerve of DPN rats treated with LTBK, MTBK and HTBK, respeFor the normal rats (Figure 1A and C), myelinated
nerve fibers were dense, the axons were fully developed,
and the thicknesses of the myelin sheaths were similar.
For the STZ-treated rats (Figure 1B and D), the myelin-
ated nerve fibers were sparsely distributed, most of
myelin sheaths were not very uniform and were demyeli-
nated. Most of the axons were swollen and some were
shriveled, and the density of the myelin sheaths was not
very uniform.showing normal sciatic nerve; B and I, Mod group, showing DPN
d with Mecobalamin; D-F and K-M, LTBK, MTBK and HTBK group,
ctively. Magnification, 400 ×).
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After 8, 10, and 12 weeks of STZ induction, the FBG
levels were significantly higher than those in the Con-
trol group (P < 0.01). For rats administered with Meco-
balamin and TBK 2 for about 2 weeks (10 weeks after
STZ induction), the FBG levels were not significantly
different from that in the Mod group. But when admin-
istered for about 4 weeks, rats in LTBK, MTBK and
HTBK groups showed a significant (P < 0.01, P < 0.05,
and P < 0.05, respectively) decrease in the levels of
blood glucose when compared with the Mod group rats
(Figure 2).Effect of TBK on thermal perception threshold
Thermal perception threshold was manifested by tail-flick
latency. A significant increase in the tail-flick latency was
observed after 8 weeks of STZ induction (p < 0.05). This
deficit in tail-flick latency was significantly reversed after
treatment with LTBK, MTBK and HTBK for four weeks
(p < 0.05) (Figure 3).Effect of TBK on nerve conduction velocity
Sciatic nerve MNCV and SNCV of all groups are
presented in Figure 4. In Mod group, both MNCV and
SNCV were significantly reduced compared with the
Control group (P < 0.01). In LTBK, MTBK and HTBK-
treated DPN rats, both MNCV and SNCV increased sig-
nificantly (P < 0.01) compared with the Mod group rats
(Figure 4).Figure 6 Ultra-microstructure of sciatic nerves. (A, Control group, show
rats; C, MCB group, showing sciatic nerve of DPN rats treated with Mecoba
rats treated with LTBK, MTBK and HTBK, respectively. Magnification, 10000×Effect of TBK on sciatic nerve morphology
HE staining of sciatic nerve showed normal structure in
control group (Figure 5A and H) and mild atrophy of
axons and diffused structure of myelinated fibers at
different density and size as well as demyelination in Mod
group (Figure 5 B and I). The morphological change of
sciatic nerve morphology in the TBK-treated rats (Figure 5
D-F and K-M) was smaller than that in Mod group.
For the rats in the Control group (Figure 6A), the fibers
were myelinated and the myelin sheaths were dense, uni-
form, and arranged as concentric rings. For the rats in the
Mod group (Figure 6B), the myelinated fibers were
broaden, loose, and partially demyelinated; For the rats in
the LTBK and MTBK groups (Figure 6D, E), the myelin
sheaths were significantly broaden, and lesser demyeli-
nated than those in the Mod group. For the rats in the
HTBK group (Figure 6A), the myelin sheath structure was
similar to that in the Control group.
Effect of TBK on inflammatory cytokines
The concentrations of pro-inflammatory cytokines TNF-α
and IL-6 were significantly increased in serum of DPN rats
when compared with the Control group rats (P < 0.01).
Administration of TBK to DPN rats for 4 weeks signifi-
cantly reduced TNF-αand IL-6 when compared with DPN
rats (Figure 7).
Effect of TBK on oxidative stress
Lower SOD and GSH-pX were found in DPN rats com-
pared with Control group rats (P < 0.01), and TBKing normal sciatic nerve; B, Mod group, showing sciatic nerve of DNP
lamin; D-F, LTBK, MTBK and HTBK group, showing sciatic nerve of DPN
).
Figure 7 Inflammatory Cytokine levels in each group. Each bar represents the mean ± S.E.M for ten rats. aP < 0.05, aaP < 0.01 vs. the Control
group. bP < 0.05, bbP < 0.01 vs. the Mod group.
Yang et al. BMC Complementary and Alternative Medicine  (2015) 15:66 Page 8 of 10treatment restored SOD and GSH-pX activity. Serum
MDA contents were significantly increased in Mod
group rats compared with those in Control group rats
(P < 0.01), and LTBK and MTBK administration for
4 weeks decreased MDA contents (Figure 8).
Discussion
DPN is manifested by MNCV and SNCV deficits as well
as by thermal perception thresholds [20]. Nerve conduc-
tion studies can be used to quantify the nerve injury in
DPN. The structural changes including axonal atrophy
and loss of myelinated nerve fibers result in the reduc-
tion of MNCV and SNCV. In our study, TBK was found
to reduce the axonal atrophy and demyelination, and
significantly reverse the deficiency of MNCV and SNCV,
and reduce the thresholds of thermal perception.
Inflammatory mediators such as cytokines have been
linked to neuropathies including DPN [21,22]. Recently,Figure 8 Oxidative stress parameters in each group. Each bar represen
group. bP < 0.05, bbP < 0.01 vs. the Mod group.increased levels of pro-inflammation cytokines IL-6 and
TNF-α have been reported in diabetic rats [23,24]. TNF-
α administration into the sciatic nerve of DPN patients
has been shown to reduce MNCV [25]. Study showed
that TNF-α- deleted diabetic mice fail to develop
changes in nociceptive behavior, MNCV, and SNCV, as
compared to diabetic mice expressing wild type TNF-α,
and that infliximab, the TNF-α neutralizing anti-body,
could recover the STZ-induced MNCV and SNCV
losses, tail flick nociceptive behavior [26]. In addition,
IL-6 can further exaggerate the inflammatory insults
seen in diabetic nerves. Thus, these studies highlight a
likely important role of TNF-α in the development of
DPN. In this study, upregulation of IL-6 and TNF-α was
observed in the serum of DPN rats. Our findings sug-
gested that TBK could significantly reduce inflammation,
which might be an important protective mechanism
against DPN.ts the mean ± S.E.M for ten rats. aP < 0.05, aaP < 0.01 vs. the Control
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measuring MDA, SOD and GSH-Px in the sciatic nerve
tissue of the STZ-induced diabetic rats [27,28]. Oxida-
tive stress has been ascribed to hyperglycemia and is
regarded as primary factor in the pathogenesis of DPN
[29,30]. Oxidative stress has been shown to result in
metabolic dysfunction in nerve fibers, and then reduce
NCV [31]. Increased oxidative stress may be associated
with an overproduction of lipid peroxide and/or a
significant decrease in the effectiveness of antioxidant
defenses. Insufficient anti-oxidative cellular mechanisms
may also be involved in nerve damage. The activities of
cellular antioxidants such as the SOD and GPX may be
crucial to this process [27,29]. In our study, a decreased
activity of primary antioxidative enzymes such as SOD
and GSH-pX in the peripheral blood of DPN rats has
been demonstrated. SOD catalyzes the oxidation/reduc-
tion/conversion of superoxide radicals to molecular oxygen
and hydrogen peroxide. GSH-pX catalyzes the hydrogen
peroxide reduction by two molecules of glutathione, a part
of reactive oxygen species defense system [32,33]. We
found a significantly increased levels of MDA and de-
creased activity of SOD and GSH-pX in DPN rats. Our
findings suggested that TBK could significantly decrease
MDA and increase the antioxidative enzyme activities in
DPN rats, which might be one of the protective mecha-
nisms against DPN.
Conclusions
The results of this study demonstrate that the thera-
peutic effect of TBK on DPN rats may be associated
with the antioxidative and anti-inflammatory responses.
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